$TCRR TCR2 THERAPEUTICS INC. Insider Trading Week 12/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TCR2 THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TCR2 THERAPEUTICS INC. in week 12/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.94 | 648 | 5,145 | 0 | 648 to 0 (-100.00 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.41 | 3,140 | 23,267 | 648 | 3.8 K to 648 (-82.89 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.83 | 3,120 | 21,310 | 3,788 | 6.9 K to 3.8 K (-45.17 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.49 | 3,009 | 19,528 | 6,908 | 9.9 K to 6.9 K (-30.34 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.60 | 17,723 | 117,043 | 9,917 | 27.6 K to 9.9 K (-64.12 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.52 | 52,000 | 338,894 | 27,640 | 79.6 K to 27.6 K (-65.29 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 217,974 | 0 | 79,640 | 297.6 K to 79.6 K (-73.24 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 196,177 | 0 | 297,614 | 493.8 K to 297.6 K (-39.73 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 212,560 | 0 | 493,791 | 706.4 K to 493.8 K (-30.09 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President & CEO | Grant | A | 10.10 | 1,287 | 12,999 | 2,267 | 980 to 2.3 K (+131.33 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President & CEO | Grant | A | 12.75 | 980 | 12,495 | 980 | 0 to 980 |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Cardama Alfonso Quintas | Chief Medical Offic ... | Grant | A | 10.10 | 1,082 | 10,928 | 1,925 | 843 to 1.9 K (+128.35 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Cardama Alfonso Quintas | Chief Medical Offic ... | Grant | A | 12.75 | 843 | 10,748 | 843 | 0 to 843 |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Somaiya Mayur Ian | Chief Financial Off ... | Grant | A | 10.10 | 1,473 | 14,877 | 3,139 | 1.7 K to 3.1 K (+88.42 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Somaiya Mayur Ian | Chief Financial Off ... | Grant | A | 12.75 | 1,666 | 21,242 | 1,666 | 0 to 1.7 K |